Navigation Links
A deadly scorpion provides a safe pesticide
Date:1/11/2010

Scorpions deliver a powerful, paralyzing venom ― a complex cocktail of poisonous peptides that immobilize animal prey on the spot. Some of the toxins in this cocktail damage only insects, which is why a Tel Aviv University researcher is harnessing them to create a safe and ecologically sound pesticide.

Prof. Michael Gurevitz of Tel Aviv University's Department of Plant Sciences has isolated the genetic sequences for important neurotoxins in the scorpion venom. He's also developed methods to produce and manipulate toxins to restrict their toxicity in certain insects or mammals.

"Two decades ago I realized that scorpion venom is a goldmine for possible insecticidal and therapeutic agents. This raised the question of how to use them as ecologically-safe agents against insects in a farmer's fields, or in medicinal disorders," he says.

In his study of the toxins and the evolution of their genes he recently published a paper in the journal Molecular Biology and Evolution that demonstrates how computational analyses at the gene sequence level leads to better understanding of how to manipulate toxin activity.

A venom factory in the lab

Rather than isolating the venom constituents of the Israeli yellow scorpion, known to be among the world's most poisonous scorpions, Prof. Gurevitz developed genetic methods for producing and manipulating the desired toxins in bacteria. He then investigated how they act against insects and mammals, paving the way for potential use in the agriculture industry.

He went in this direction because attempts to insert a certain neurotoxin gene into a plant genome hoping for the plant to produce the toxin and kill infesting insects has failed. As a peptide, the toxin was metabolized in the insect guts, which evidently seems to require that it first be engineered to be able to penetrate into the insect blood stream to have its impact on the nervous system.

Prof. Gurevitz says that some neurotoxins in the scorpion are highly active against some insects ― leaf-eating moths, locusts, flies and beetles ― but have no effect on beneficial insects like honeybees or on mammals like humans. He continues to pursue an effective mode of delivery for what could be a new insecticide.

Prof. Gurevitz is considered one of the world's pioneers in this field, having published numerous papers on this subject. He spent six years as a research fellow at Washington University in St. Louis and Michigan State University, beginning his scorpion studies while an M.Sc. student in Jerusalem 35 years ago. Since then, he's developed methods of toxin gene cloning, production and modification in his lab, paving the way for an entirely new molecular field based on the venom of the deadly insect.

A "Trojan crop" to hide a deadly poison

Since scorpion toxins must be modified to be able to penetrate the blood stream of an infesting insect, it is important to study the toxins and the way they interact with the insect nervous system. Only then would it be possible to modify them in such a way as to reach their target tissues in insects, he says. This is the direction he is working on now.

The agriculture industry already uses mostly pyrethroids, which also penetrate into insects and attack their nervous systems, leading to paralysis and death. Their main drawback, however, is the lack of specificity and the danger these compounds pose to the environment, livestock and humans.

"Why not harness potent natural compounds that venomous animals developed during millions of years of evolution?" asks Prof. Gurevitz. "I am developing the science so we can learn how to use them, and to learn how to produce agents to mimic their effect yet maintain specificity to certain kinds of insects."


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related biology news :

1. Scripps research team blocks bacterial communication system to prevent deadly staph infections
2. Northwestern to expose most deadly infectious diseases in 3-D
3. Best treatment identified to reduce deadly Staph infections
4. Research unveils new hope for deadly childhood disease
5. Deadly genetic disease prevented before birth in zebrafish
6. Ayurvedic nightshade deadly for dengue mosquito
7. Sydney harbors deadly diet for sea creatures
8. New vaccine may give long-term defense against deadly bird flu and its variant forms
9. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
10. Deadly rugby virus spreads in sumo wrestlers
11. 15-state Southern obesity summit to focus on deadly epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology: